MediShield Life and some Integrated Shield Plans cover off-label use of drugs to treat cancer

Singapore's Integrated Shield Plan insurers' coverage of cancer drug treatments is subject to their terms and conditions. PHOTO: PEXELS
Gift this subscriber-only story to your friends and family

SINGAPORE - Oncologists say they often use drugs "off label" to treat cancers, especially after conventional treatments fail.

Off label refers to the use of an otherwise approved drug in a setting for which it has not received regulatory approval. This could be because the drug is still new and clinical trials for its use for certain conditions are ongoing. Or it could be because the drug company does not think it is worth the expense and effort to get it approved.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.